v3.25.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Cash Flows from Operating Activities        
Net loss $ (2,620,369) $ (782,294) $ (1,171,439) $ (348,288)
Adjustments to reconcile net loss to net cash used in operating activities        
Depreciation 33,200 0    
Amortization 155,788 42,182 58,754 32,585
Amortization of debt discount 625,614 0    
Stock based compensation expense 303,152 75,410    
Financing cost 82,609 0    
Impairment of Intangible Asset     198,193 0
Change in fair value of derivative financial instruments (15,110) 0    
Shares issued for loan and interest 0 224,000    
Shares Issued for Services     58,000 122,000
Loss on conversion of convertible note to common stock 0 (376,000) 426,000 0
Shares Issued as gift     17,410 0
Shares Issued for Loan & Interest     120,000 60,000
Loss on exercise of warrants     60,000 0
Changes in assets and liabilities        
Accounts Payable (6,482) 44,040 44,214 26,618
Prepaid Expenses     30,000 (30,000)
Payroll Payable     84,512 50,488
Accrued Interest     33,701 4,303
Due to related party 27,582 9,583 6,557 1,468
Right of use lease asset (35,139) 0    
Payroll payable 0 81,000    
Accrued interest 1,441 10,351    
Lease liability (35,139) 0    
Net cash provided by (used in) operating activities (1,412,575) 80,272 (34,098) (80,827)
Cash Flows from Investing Activities        
Software     (85,871) (74,173)
Acquisition of fixed assets and software (1,089) (90,274)    
Net cash used in investing activities (1,089) (90,274) (85,871) (74,173)
Cash Flows from Financing Activities        
Shares issued for cash     30,000 100,000
Promissory Note     90,000 55,000
Proceeds from issuance of convertible notes 1,485,900 10,000    
Repayment of promissory notes (55,000) 0    
Net cash provided by financing activities 1,430,900 10,000 120,000 155,000
Net increase (decrease) in Cash 17,236 (2) 31 1
Net Change in Cash        
Cash at beginning of period 33 2 2 1
Cash at end of period 17,269 0 33 2
Supplemental disclosure of cash flow information:        
Cash paid during the period for interest 14,004 0    
Cash paid during the period for income tax 0 0    
Noncash Investing and Financing Items [Abstract]        
Contingent equity consideration issued in acquisition 14,605,921 0    
Shares issued for conversion of notes     540,000 0
Forgiveness of Accrued payroll     $ 135,000 $ 0
Conversion of contingent equity consideration payable to equity 11,281,541 0    
Conversion of Series A Preferred Stock to Class A Common Stock 75 0    
Conversion of convertible debt to equity 840,675 0    
Recognition of operating lease: right of use asset and lease liability 96,347 0    
Fair value of warrants issued as deferred offering cost 990,614 0    
Fair value of convertible debt beneficial conversion feature allocated to proceeds of debt 491,700 0    
Fair value of warrants allocated to proceeds of debt 178,935 0    
Fair value of common shares allocated to proceeds of debt 24,838 0    
Fair value of shares issuable as deferred offering cost 450,000 0    
Contingent equity consideration payable from acquisition $ 3,323,192 $ 0